Analyst Recommendations

Citigroup analyst issues BUY recommendation for ABNB on October 17, 2024 05:49AM ET. The previous analyst recommendation was Buy.ABNB was trading at $135.15 at issue of the analyst...

October 17, 2024   ABNB -2.34%

Bernstein analyst issues OUTPERFORM recommendation for GILD on October 17, 2024 05:49AM ET. GILD was trading at $86.75 at issue of the analyst recommendation.The overall analyst consensus :...

October 17, 2024   GILD 0.64%

Bernstein analyst issues OUTPERFORM recommendation for LLY on October 17, 2024 05:49AM ET. LLY was trading at $916.42 at issue of the analyst recommendation.The overall analyst consensus :...

October 17, 2024   LLY 3.39%

Citigroup analyst issues BUY recommendation for STLD on October 17, 2024 05:48AM ET. The previous analyst recommendation was Buy.STLD was trading at $129.86 at issue of the analyst...

October 17, 2024   STLD -2.28%

Citigroup analyst issues NEUTRAL recommendation for REXR on October 17, 2024 05:48AM ET. The previous analyst recommendation was Neutral.REXR was trading at $49.41 at issue of the analyst...

October 17, 2024   REXR -0.74%

Bernstein analyst issues MARKET PERFORM recommendation for BMY on October 17, 2024 05:50AM ET. BMY was trading at $53.37 at issue of the analyst recommendation.The overall analyst consensus...

October 17, 2024   BMY 1.74%

Evercore ISI analyst issues OUTPERFORM recommendation for CSX on October 17, 2024 05:53AM ET. The previous analyst recommendation was Outperform.CSX was trading at $35.47 at issue of the...

October 17, 2024   CSX -0.26%

Evercore ISI analyst issues OUTPERFORM recommendation for MS on October 17, 2024 05:54AM ET. The previous analyst recommendation was Outperform.MS was trading at $119.51 at issue of the...

October 17, 2024   MS -1.61%

Bernstein analyst issues MARKET PERFORM recommendation for MRK on October 17, 2024 05:50AM ET. MRK was trading at $110.42 at issue of the analyst recommendation.The overall analyst consensus...

October 17, 2024   MRK 1.52%

Bernstein analyst issues MARKET PERFORM recommendation for MRNA on October 17, 2024 05:51AM ET. MRNA was trading at $57.46 at issue of the analyst recommendation.The overall analyst consensus...

October 17, 2024   MRNA -4.97%